These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 10323591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R, Hiley CR.
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N, Bukoski RD.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
    [Abstract] [Full Text] [Related]

  • 5. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent.
    Mukhopadhyay S, Chapnick BM, Howlett AC.
    Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2046-54. PubMed ID: 12003810
    [Abstract] [Full Text] [Related]

  • 6. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA, Varga K, Járai Z, Kunos G.
    Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [Abstract] [Full Text] [Related]

  • 7. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V.
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC, Martin BR, Ellis EF.
    Biochem Pharmacol; 1996 Mar 08; 51(5):669-76. PubMed ID: 8615904
    [Abstract] [Full Text] [Related]

  • 10. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.
    Chaytor AT, Martin PE, Evans WH, Randall MD, Griffith TM.
    J Physiol; 1999 Oct 15; 520 Pt 2(Pt 2):539-50. PubMed ID: 10523421
    [Abstract] [Full Text] [Related]

  • 11. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
    Al Kury LT, Voitychuk OI, Ali RM, Galadari S, Yang KH, Howarth FC, Shuba YM, Oz M.
    Cell Calcium; 2014 Feb 15; 55(2):104-18. PubMed ID: 24472666
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF, Hillard CJ, Edgemond WS, Campbell WB.
    Am J Physiol; 1998 Jan 15; 274(1):H375-81. PubMed ID: 9458889
    [Abstract] [Full Text] [Related]

  • 14. Studies on the effects of anandamide in rat hepatic artery.
    Zygmunt PM, Högestätt ED, Waldeck K, Edwards G, Kirkup AJ, Weston AH.
    Br J Pharmacol; 1997 Dec 15; 122(8):1679-86. PubMed ID: 9422814
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
    Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP.
    Br J Pharmacol; 1997 Aug 15; 121(8):1509-11. PubMed ID: 9283682
    [Abstract] [Full Text] [Related]

  • 17. Anandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes.
    Li Q, Cui N, Du Y, Ma H, Zhang Y.
    PLoS One; 2013 Aug 15; 8(5):e63386. PubMed ID: 23667607
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
    Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D.
    Eur J Pharmacol; 1997 Dec 11; 340(2-3):R7-8. PubMed ID: 9537804
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
    Fleming I, Schermer B, Popp R, Busse R.
    Br J Pharmacol; 1999 Feb 11; 126(4):949-60. PubMed ID: 10193775
    [Abstract] [Full Text] [Related]

  • 20. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM, Kirkham TC.
    Psychopharmacology (Berl); 1999 Apr 11; 143(3):315-7. PubMed ID: 10353436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.